Cite
Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death.
MLA
Arif S, et al. “Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death.” Diabetes, vol. 60, no. 8, Aug. 2011, pp. 2112–19. EBSCOhost, https://doi.org/10.2337/db10-1643.
APA
Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, Vives-Pi M, Powrie J, Tree T, Marchetti P, Huang GC, Gurzov EN, Pujol-Borrell R, Eizirik DL, Peakman M, Arif, S., Moore, F., Marks, K., Bouckenooghe, T., & Dayan, C. M. (2011). Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes, 60(8), 2112–2119. https://doi.org/10.2337/db10-1643
Chicago
Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, Vives-Pi M, et al. 2011. “Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death.” Diabetes 60 (8): 2112–19. doi:10.2337/db10-1643.